XBiotech Inc Total Liabilities

Latest as of December 2025: $9.73 Million USD

XBiotech Inc total liabilities. Based on the latest financial reports, XBiotech Inc (XBIT) has total liabilities worth $9.73 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check asset resilience ratio of XBiotech Inc to evaluate the company's liquid asset resilience ratio.

Total Liabilities of XBiotech Inc (2012–2025)

Total liabilities of XBiotech Inc from 2012 to 2025. This chart illustrates how XBiotech Inc's total liabilities have evolved over time, based on quarterly financial data.

XBiotech Inc Competitors by Total Liabilities

The table below lists competitors of XBiotech Inc ranked by their total liabilities.

Company	Country	Total Liabilities
First Seacoast Bancorp NASDAQ:FSEA	USA	$546.47 Million
Talaad Thai Leasehold Property Fund BK:TTLPF	Thailand	฿42.32 Million
Cross Timbers Royalty Trust NYSE:CRT	USA	$1.51 Million
Quartiers Properties AB (publ) ST:QUART-PREF	Sweden	Skr218.07 Million
Bathurst Resources Ltd AU:BRL	Australia	AU$22.78 Million
Nan Ren Hu Leisure Amusement Co Ltd TWO:5905	Taiwan	NT$3.78 Billion
Mercury Securities Group Berhad KLSE:0285	Malaysia	RM18.02 Million
Samchem Holdings Bhd KLSE:5147	Malaysia	RM303.92 Million

Liability Composition Analysis (2012–2025)

This chart breaks down XBiotech Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see balance sheet size of XBiotech Inc.

Liquidity & Leverage Metrics

XBiotech Inc Total Liabilities Ratios Explained

XBiotech Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.

Metric	Value	Description
Current Ratio	16.01	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.07	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.06	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how XBiotech Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for XBiotech Inc (2012–2025)

The table below shows the annual total liabilities of XBiotech Inc from 2012 to 2025.

Year	Total Liabilities	Change
2025-12-31	$9.73 Million	-42.16%
2024-12-31	$16.82 Million	+116.57%
2023-12-31	$7.77 Million	+36.27%
2022-12-31	$5.70 Million	-1.57%
2021-12-31	$5.79 Million	+13.46%
2020-12-31	$5.11 Million	-91.66%
2019-12-31	$61.25 Million	+1978.25%
2018-12-31	$2.95 Million	+4.88%
2017-12-31	$2.81 Million	-64.81%
2016-12-31	$7.99 Million	+26.60%
2015-12-31	$6.31 Million	+100.44%
2014-12-31	$3.15 Million	+272.43%
2013-12-31	$845.00K	-22.97%
2012-12-31	$1.10 Million	--

About XBiotech Inc

NASDAQ:XBIT USA Biotechnology

Market Cap

$59.45 Million

Market Cap Rank

#21038 Global

#4749 in USA

Share Price

$1.95

Change (1 day)

-2.01%

52-Week Range

$1.85 - $2.94

All Time High

$21.49